Senior insider sale
Interim CFO at AVALO THERAPEUTICS, INC. — senior position signals high conviction
$1.85M
98.48K shares
What this filing means
SULLIVAN CHRISTOPHER RYAN plans to sell 98.48K shares of AVALO THERAPEUTICS, INC. valued at approximately $1.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/7/2026ACC: 0001950047-26-004199
Officer· Interim CFO
Since Apr 2020
98.48K
Shares to sell
$1.85M
Approx. market value
18.61K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
5/7/2026
18.61KTotal acquired18.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/7/2026 | Exercise of Stock Options Cash | 18.61K | — |
| Total | 18.61K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
47K
Market value
$948.7K
5/6/2026
—Completed
Units to sell
8.46K
Market value
$111.9K
4/30/2026
—Completed
Units to sell
8.46K
Market value
$110.7K
4/29/2026
—Completed
Units to sell
7.98K
Market value
$136.8K
4/2/2026
—Completed
Units to sell
7.98K
Market value
$133.8K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
18.61K
Market value
$405.8K
5/7/2026
Total
Units
98.48K
Value
$1.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/6/2026 | 47K | $948.7K | — | Completed |
4/30/2026 | 8.46K | $111.9K | — | Completed |
4/29/2026 | 8.46K | $110.7K | — | Completed |
4/2/2026 | 7.98K | $136.8K | — | Completed |
4/1/2026 | 7.98K | $133.8K | — | Completed |
| Planned — Approximate Date | ||||
5/7/2026 | 18.61K | $405.8K | NASDAQ | Planned |
| Total | 98.48K | $1.85M | ||